<?xml version="1.0" encoding="UTF-8"?>
<p>The major common thread linking COVID-19 and TB (
 <xref rid="TB1" ref-type="table">table 1</xref>) is that both, in different ways, have natural capacities to stress the national health care system. The recent epidemic of COVID-19 in Italy highlights how a rapid spread of a serious epidemic could severely affect healthcare systems in the world. Shortages of Personal Protective Devices, mechanical ventilators, and worse, beds in intensive care units are a serious sign that health system cannot adapt rapidly to a health emergency [
 <xref rid="C3" ref-type="bibr">3</xref>]. On the contrary, TB is a “silent” epidemic [
 <xref rid="C4" ref-type="bibr">4</xref>]. The New York epidemic in the early 1990s taught us that as soon as TB drops off the radar of public health and politics, the effects can be catastrophic on its epidemiology and the resulting public spending. By 1990, New York city accounted for more than 15% of the country's cases and the federal government needed to spend more than 1$ billion to contain the MDR-TB outbreak [
 <xref rid="C5" ref-type="bibr">5</xref>]. Likewise, COVID-19 will lead to devastating economic effects even for the wealthiest regions of Italy that are currently affected. 
</p>
